Simon Dang Van

David Boulate¹, 

Myriam Amsallem^1,2, 

Jean-Baptiste Menager¹, 

Simon Dang Van¹, 

Peter Dorfmuller³, 

Andrew Connolly⁴, 

Alban Todesco⁵, 

Benoit Decante¹, 

Elie Fadel¹, 

Francois Haddad², 

Olaf Mercier¹ 

¹Research and Innovation Unit, RHU BioArt Lung 2020, Marie Lannelongue Hospital, 

²Phenotypic and Biomarker Core Laboratory, Cardiovascular Institute, Stanford University, 

³Department of pathology, Marie Lannelongue Hospital, 

⁴Department of pathology, UCSF School of Medicine, 

⁵Department of thoracic surgery, Hopital Nord, APHM, Aix-Marseille University 

Simon Dang Van^1,2,3, 

Dorothée Brunet^1,2,3, 

Ali Akamkam^1,2,3, 

Benoit Decante^1,2, 

Julien Guihaire^1,2,3 

¹Laboratory of Preclinical Research, Department of Research and Innovation, Groupe Hospitalier Paris Saint Joseph, 

²Inserm UMR S 999, Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Groupe Hospitalier Paris Saint Joseph, 

³Department of Cardiac Surgery, Marie Lannelongue Hospital